论文部分内容阅读
目的探讨对冠心病患者实施心理干预的临床效果。方法将120名住院冠心病患者随机分为干预组和对照组各60人,两组均接受心内科常规治疗,干预组在此基础上按照既定的干预方案进行心理干预,采用两组间干预前后对照的方法,运用自测健康评定量表(SRHM S)和西雅图心绞痛调查量表(SAQ)于干预前后评价所有入选患者,比较两组临床疗效。结果干预前,两组SRHM S和SAQ评分均无显著性差异(P>0.05),干预后进行干预效果调查,干预组在自测健康的3个维度和总得分上的差值高于对照组(t=2.772,7.779,6.403,7.035;P<0.01);干预组在心绞痛发作状态、治疗满意度和疾病认识程度3个维度及西雅图总分上的差值也都明显高于对照组(t=1.015,8.774,6.771,9.972,P<0.01),且干预组的临床疗效显著高于对照组(2χ=16.536,P<0.01),干预组平均住院天数明显缩短。结论心理干预能有效改善冠心病患者的心身症状,提高临床治疗效果。
Objective To investigate the clinical effect of psychological intervention in patients with coronary heart disease. Methods 120 hospitalized patients with coronary heart disease were randomly divided into intervention group and control group of 60 people, both groups received routine cardiology treatment, the intervention group on the basis of the intervention program in accordance with the established psychological intervention, using the two groups before and after intervention The control group was evaluated for all patients before and after intervention by using the Self-rated Health Assessment Scale (SRHM S) and the Seattle Angina Stress Scale (SAQ), and the clinical efficacy was compared between the two groups. Results Before intervention, there was no significant difference between the two groups in SRHM S and SAQ scores (P> 0.05). After the intervention, the effect of intervention was investigated. The difference between the three dimensions of self-rated health and total score in intervention group was higher than that in control group (t = 2.772,7.779,6.403,7.035; P <0.01). The intervention group also had significantly higher differences in angina pectoris status, treatment satisfaction and disease awareness, and Seattle differences = 1.015,8.774,6.771,9.972, P <0.01). The clinical efficacy of the intervention group was significantly higher than that of the control group (2χ = 16.536, P <0.01). The average length of stay in the intervention group was significantly shorter. Conclusion Psychological intervention can effectively improve the psychosomatic symptoms of patients with coronary heart disease and improve the clinical effect.